TCRR
TCR2 Therapeutics Inc. Common Stock
TCRR
TCRR
Delisted
TCRR was delisted on the 31st of May, 2023.
33 hedge funds and large institutions have $114M invested in TCR2 Therapeutics Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$1.51M | |
| 2 | +$1.07M | |
| 3 | +$576K | |
| 4 |
Charles Schwab
San Francisco,
California
|
+$349K |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$231K |
Top Sellers
| 1 | -$1.42M | |
| 2 | -$984K | |
| 3 | -$694K | |
| 4 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
-$458K |
| 5 |
Norges Bank
Oslo,
Norway
|
-$436K |